Should risky treatments be reserved for secondary prevention? Theoretical considerations regarding risk–benefit tradeoffs

Abstract

This framework provides a rationale for extending the familiar concept of balancing risks and benefits to account for disease-specific considerations of primary vs. secondary prevention.